Literature DB >> 17726041

European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts).

Ian Graham1, Dan Atar, Knut Borch-Johnsen, Gudrun Boysen, Gunilla Burell, Renata Cifkova, Jean Dallongeville, Guy De Backer, Shah Ebrahim, Bjørn Gjelsvik, Christoph Herrmann-Lingen, Arno Hoes, Steve Humphries, Mike Knapton, Joep Perk, Silvia G Priori, Kalevi Pyorala, Zeljko Reiner, Luis Ruilope, Susana Sans-Menendez, Wilma Scholte op Reimer, Peter Weissberg, David Wood, John Yarnell, Jose Luis Zamorano, Edmond Walma, Tony Fitzgerald, Marie Therese Cooney, Alexandra Dudina.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17726041     DOI: 10.1093/eurheartj/ehm316

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  310 in total

1.  Randomized controlled trial on the long-term efficacy of a multifaceted, interdisciplinary lifestyle intervention in reducing cardiovascular risk and improving lifestyle in patients at risk of cardiovascular disease.

Authors:  Lysanne Goyer; Robert Dufour; Caroline Janelle; Chantal Blais; Christine L'Abbé; Emilie Raymond; Jacques de Champlain; Pierre Larochelle
Journal:  J Behav Med       Date:  2012-03-09

Review 2.  Is heart rate a treatment target in heart failure?

Authors:  Jan-Christian Reil; Michael Böhm
Journal:  Curr Cardiol Rep       Date:  2012-06       Impact factor: 2.931

3.  Potential cardiovascular consequences of switching from atorvastatin to generic simvastatin in the Netherlands.

Authors:  D Liew; K Webb; W-J Meerding; E Buskens; J W Jukema
Journal:  Neth Heart J       Date:  2012-05       Impact factor: 2.380

4.  [Primary prevention of coronary artery disease: is there a role for risk scores?].

Authors:  H Gohlke
Journal:  Herz       Date:  2012-02       Impact factor: 1.443

5.  [Cardiovascular risk factors and Primary Care: evaluation and intervention].

Authors:  José María Lobos Bejarano; Carlos Brotons Cuixart
Journal:  Aten Primaria       Date:  2011-11-17       Impact factor: 1.137

6.  Appropriateness of antiplatelet therapy for primary and secondary cardio- and cerebrovascular prevention in acutely hospitalized older people.

Authors:  Ilaria Ardoino; Raffaella Rossio; Donnatella Di Blanca; Alessandro Nobili; Luca Pasina; Pier Mannuccio Mannucci; Flora Peyvandi; Carlotta Franchi
Journal:  Br J Clin Pharmacol       Date:  2017-08-01       Impact factor: 4.335

7.  Cardiovascular disease and perceived weight, racial, and gender discrimination in U.S. adults.

Authors:  Tomoko Udo; Carlos M Grilo
Journal:  J Psychosom Res       Date:  2017-07-13       Impact factor: 3.006

Review 8.  Perspectives of I(f) inhibition by ivabradine in cardiology.

Authors:  Michael Böhm; Jan-Christian Reil
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 9.  Cardiovascular risk associated with nonsteroidal anti-inflammatory drugs.

Authors:  Matthias Hermann
Journal:  Curr Rheumatol Rep       Date:  2009-02       Impact factor: 4.592

Review 10.  Heart rate as an independent risk factor for cardiovascular disease: current evidence and basic mechanisms.

Authors:  Paolo Palatini
Journal:  Drugs       Date:  2007       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.